Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Symptom interference negatively affects quality of life in women with ovarian cancer.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Alopecia Areata affects daily life but can lead to new activities.

People with lupus in Mauritius face many challenges and need more support and understanding.

TikTok videos show that people with Lupus often discuss symptoms and their significant impact on mental health, face diagnostic delays, have mixed views on treatments, and feel isolated despite support.

Lupus patients on TikTok feel isolated, face medical gaslighting, and prefer non-drug treatments.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Platelet-rich plasma therapy can reduce hair loss and enhance hair growth in androgenetic alopecia patients, with no side effects observed.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Men can experience female pattern hair loss, needing different treatments.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

People with alopecia areata often experience negative personal, social, and medical impacts, and need psychological support.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Finasteride 1mg is effective and safe for long-term use in treating male hair loss.